trial · primary record
Obecabtagene autoleucel
Lupus Nephritis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 35 |
| Primary completion | 2029-10 |
| Primary endpoint | Proportion of participants who achieve complete renal response (CRR) |
| Registry ID | NCT07053800 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:51.421Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07053800
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.